Finance

Lists
DMAA:NASDAQ
Drugs Made In America Acquisition Corp
$10.84
0.00%
(0.00) 1D
Sep 17, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DMAA...
Mkt. cap
263.16M
Avg. vol.
33.32K
Volume
0.00
P/E ratio
51.70
52-wk high
$10.86
52-wk low
$10.26
EPS
$0.21
Shares outstanding
24.28M
Mkt. cap
263.16M
Avg. vol.
33.32K
Volume
0.00
P/E ratio
51.70
52-wk high
$10.86
52-wk low
$10.26
EPS
$0.21
Shares outstanding
24.28M
News stories
From web sources and news partners
About Drugs Made In America Acquisition Corp
CEO-
Employees-
Founded2024
Headquarters-
SectorCapital market
Websitedmaacorp.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
263.70K
2.09M
143.30K
136.93K
Operating expense
263.70K
2.09M
143.30K
136.93K
Total operating expenses
263.70K
2.09M
143.30K
136.93K
Operating income
-263.70K
-2.09M
-143.30K
-136.93K
Other non operating income
-
-
-
-
EBT including unusual items
2.18M
212.96K
1.97M
1.73M
EBT excluding unusual items
2.18M
212.96K
1.97M
1.73M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
2.18M
212.96K
1.97M
1.73M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2.45M
2.30M
2.11M
1.86M
Interest expense
-
-
-
-
Net interest expenses
2.45M
2.30M
2.11M
1.86M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps